Branded generic manufacturers are focused on emergency stocks and alternatives for supply options to minimize risk of supply and distribution disruptions during the crisis period.

DUBAI, UAE / ACCESSWIRE / August 26, 2020 / The branded generics market is expected to reflect a highly promising 8% CAGR between 2020 and 2030. The branded generics market is likely to gain key growth opportunities for the duration of the coronavirus pandemic. Demand for low cost treatments for the virus and investments into drug research during this period is likely to support market growth in the short term.

"Branded generics are largely used as alternative drugs to innovator offerings from the pharma industry following the expiration patents. The global market for branded generics expected to display steady growth as a large number of pharmaceutical products are witnessing the expiry of their patents during the assessment period," states the FMI analyst.

Download a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-1260

Branded Generics Market- Critical Takeaways

Cardiovascular treatment applications account for substantial demand, owing to the expiry of multiple patents in the category.
Pharmacies and drug stores are major channels of distribution, supported by promotional activity and easier access to consumers.
Europe is a prominent market for branded generics owing to demand for alternatives to expensive patented medication options.

Branded Generics Market- Drivers

Regular expiration of branded drug patents, coupled with higher profit margins of branded generics supports market growth.
Simplification of market authorization processes is a key driver of growth opportunities.

Branded Generics Market- Restraints

High competition from commodity generics and branded drugs hinders sales and revenue.
Misconceptions of quality associated with branded generics hinders adoption rates.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-1260

Coronavirus Impact on Branded Generics Market

The branded generics market is expected to be marginally impacted by the coronavirus contagion. The potential slowdown of sales in China is a major factor of concern. In addition, patients are not as likely to actively seek prescription renewals and or healthcare services, which could reduce demand. Also, manufacturers who depend on China for drug ingredients could face supply disruptions. On the other hand, manufacturers with alternative suppliers on hand can capitalize on the pandemic by increasing drug prices and eating away at market share of their competitors.

Competitive Landscape

Mylan, Novartis, Pfizer, Teva, and Abbott Laboratories are some of the leading players in the branded generics market.

Manufacturers in the branded generics market are increasingly displaying interest in product launch strategies to keep the edge in a competitive market, expand portfolios, and bolster profit margins with formulations of expired patents.

For instance, Dr. Reddy's Laboratories Ltd. has announced the release of AVIGAN a branded favipiravir generic for covid-19 treatment. Hikma Pharmaceuticals plc has launched Everolimus tablets, which is a generic version of Zortress used in transplant treatments. Lilly has also announced the release of branded generic versions of KwikPen and Humalog protamine and insulin suspensions.

Buy Now@ https://www.futuremarketinsights.com/checkout/1260

About the Study

The study offers readers a comprehensive assessment of the Branded generics market. Global, regional and national-level analysis of the latest trends influencing the branded generics market is covered in this FMI report. The study provides insights according to therapeutic application (oncology, cardiovascular disease, diabetes, neurology, gastrointestinal disease, dermatology disease, analgesics and anti-inflammatory, and others), drug class (alkylating agents, antimetabolites, hormones, anti-hypertensive, lipid lowering drugs, anti-depressants, anti-psychotics, anti-epileptics, and others) formulation type (oral, parenteral, topical, and others), and distribution channel (hospital pharmacies, retail pharmacies, online pharmacies, and drug stores) in seven regions (North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and MEA).

Explore FMI's Coverage of the Healthcare, Pharmaceuticals, and Medical Devices Industry

Microfluidics Market– Get insights on the global microfluidics market through FMI's report covering detailed quantitative and qualitative analysis for projection period 2016-2026.

Electronic Medical Records (EMR) Market– FMI's exhaustive study on the electronic medical records (EMR) market covers the latest trends, innovations, key players, and popular strategies for the period 2015-2025.

Clinical Trials Market– Obtain detailed analysis on the clinical trials market through FMI's report covering competitive analysis, key regions, and segmental analysis.

About Future Market Insights

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/branded-generics-market
Press Release Source: https://www.futuremarketinsights.com/press-release/branded-generics-market

SOURCE: Future Market Insights

ReleaseID: 603434

Leading players in the technical textile market are investing extensively in the diversification of raw material sources, owing to disruptions in supplies from Chinese manufacturers.

DUBAI, UAE / ACCESSWIRE / August 26, 2020 / The technical textiles market is anticipated to display a healthy growth rate during the assessing period between the years 2020 and 2030. The covid-19 pandemic has moderately affected the global technical textiles industry. Major production disruptions, owing to lockdown restrictions, coupled with the major slump in industrial and construction activity hinders short term market growth.

"Growth in the demand for technical construction textiles, in addition to favorable investments and initiatives by governments to promote technical textile applications are fueling the demand throughout the projection period," says the FMI report.

Download a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-286

Technical Textiles – Primary Takeaways

Nanomaterial and nanofiber production processes are rapidly gaining ground in technical textile applications owing to antibacterial, and chemical resistance characteristics.
Agro-textiles are finding growing roles in revenue generation, with solar-radiation, and weather resistant applications.
Europe is likely to display impressive growth as a technical textile market supported by major investments in healthcare and fashion applications.

Technical Textiles – Growth Factors

Wide scope of application for technical textiles including packaging, agriculture, aerospace, and construction sectors help to sustain long-term growth.
Improvements in terms of recyclability of technical textiles bolster overall adoption rates.

Technical Textiles – Major Constraints

High processing and production costs for technical textile remains a major challenge for manufacturers.
Cost and expertise required for operating in the technical textiles market is a major hinderance, for small and medium enterprises.

For information on the Research Approach used in the Report, Request Methodology@ https://www.futuremarketinsights.com/askus/rep-gb-286

The Projected Impact of Coronavirus

The technical textile industry has been moderately impacted during the coronavirus pandemic. Lockdown restrictions on construction and industrial activities have reduced demand for technical textiles sharply. In addition, nationwide lockdowns have restricted supplies and production of technical textiles as well. On the other hand, extensive requirement for specialized technical textiles for healthcare PPE production during the pandemic has generated critical growth opportunities to recoup some of the losses sustained during this period.

Competition Landscape

The technical textiles market comprises players including but not limited to Freudenberg & Co. KG, Low and Boar plc, Baltex, Ahlstrom Corp., Dickson-Constant, E.I. du Pont de Nemours and Company, Miliken and Co., Avintiv, and 3M Company.

Players operating in the technical textiles market are leveraging government initiatives and are pushing for product development particularly in the medical sector following the coronavirus outbreak.

For instance, Hygienics Industry Inc. has unveiled Fabrapel two-layer, technical textile for facial mask applications. Similarly, Loyal Textile Mills has launched technical textile with anti-viral technology for reusable PPE applications. Also, Duvaltex has released a complete range of level 1 and 2 anti-microbial textile gowns for patients and healthcare professionals in the U.S.

Request a Discount for this Report@ https://www.futuremarketinsights.com/request-discount/rep-gb-286

More About the Study

The FMI study provides detailed insights on technical textiles. The market is broken down in terms of application (agro-tech, buildtech, hometech, indutech, sportech, packtech, mobiltech, meditech, clothtech, Geotech, protech, and oekotech), and process type (nonwoven, composite, and others), across six key regions (North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, and MEA).

Explore Future Market Insights Coverage of the Chemicals & Materials Industry

Biophotonics Market: Find insights on the biophotonics market with segment analysis, statistics, influencing factors, players and key strategies adopted by market players for a 6-year forecast period.

Antimicrobial Additives Market: FMI's report on the antimicrobial additives market offers details on the market between 2015 -2025. The study covers influencers, revenue sources, market leaders, and strategies.

India Construction Chemical Market: Get an in-depth analysis on the India construction chemical market with insights on growth levers, opportunities, policies, restraints, regional markets and market leaders.

About Future Market Insights

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/technical-textiles-market
Press Release Source: https://www.futuremarketinsights.com/press-release/global-technical-textiles-market

SOURCE: Future Market Insights

ReleaseID: 603433

Submersible pump manufacturers are pushing to leverage waste water, irrigation, and municipal applications to sustain limited sales and operations throughout the covid-19 pandemic.

ROCKVILLE, MD / ACCESSWIRE / August 26, 2020 / The submersible pumps market is estimated to display steady growth to reach a valuation of US$ 12.2 billion from 2020 to 2030. The coronavirus pandemic is expected to have impact demand for submersible pumps in the short term largely owing to the suspension of industrial activities in multiple sectors, and the resultant drop in industrial and slurry pumping. Demand is likely to recover with the relaxation of lockdown rules towards 2021.

"National oil companies are increasingly investing in new naphtha crackers. A number of brownfield refinery expansion projects, particularly in the Asia Pacific are expected to boost demand for submersible pumps throughout the forecasting period," says the Fact.MR analyst.

Request a report sample to gain more market insights at

https://www.factmr.com/connectus/sample?flag=S&rep_id=4818

Submersible Pumps Market – Important Takeaways

Mining sector applications account for major revenue share, supported by the recent growth in metal production facilities.
Grinder submersible pumps are anticipated to witness significant growth on the back of investments in sewage and wastewater applications.
Asia Pacific is a major market for submersible pumps owing to growing hydrocarbon production and exploration efforts in the country.

Submersible Pumps Market – Driving Factors

Applications of submersible pumps are growing in agricultural endeavors owing to national and international food security requirements.
Strict policies and regulations for water resources and wastewater handling are key factors driving demand for submersible pumps.

Submersible Pumps Market – Leading Constraints

High expenses in terms of repairing failed submersible pumps is a major challenge for adoption.
Single stage submersible pumps are limited in scope of multifunctional applications, hindering demand.

Anticipated Market Impact by Coronavirus Outbreak

The coronavirus outbreak has had a negative impact on the submersible pumps market largely owing to the disruption of activities in multiple industrial sectors that involve water pumping processes. Further, lockdown restrictions, and health fears in mining, and offshore exploration and production operations are likely to impact market growth. Disruptions in supplies of essential components are detrimental to growth prospects. However, the market is likely to recover steadily towards 2021, as lockdown restrictions on end user industries are relaxed.

Explore the global submersible pumps market with 126 figures, 70 data tables, along with the table of contents of the report. You can also find detailed segmentation on https://www.factmr.com/report/4818/submersible-pump-market

Competition Landscape

Leading manufacturers in the consolidated submersible pumps market include but are not limited to Sumitomo Heavy Industries Ltd., Kubota Corp., Ingeroll-Rand Plc, Wacker Neuson Group, Tsurumi Manufacturing Co., Atlas Copco Group, the Weir Group plc, KSB SE & Co. KGaA, Sulzer AG, and Xylem Inc.

Leading manufacturers in the submersible pumps market have been largely pushing for product launch and innovations strategies to expand portfolios and keep up with changing user needs.

For instance, Tsurumi Manufacturing Co. has released HS Series high performance drainage pumps for dewatering applications. Upwing Energy has unveiled a patent for high-efficiency electric motor configuration for downhole submersible systems. Warman has unveiled SHW submersible slurry pumps for high performance mining dewatering applications.

More on the Report

The FACT.MR's market research report provides in-depth insights on submersible pumps market. The market is scrutinized according to product (borewell, non-clog, openwell), head type (below 50 meters, 50 – 100 meters, and above 100 meters), and application (agriculture, construction, fire-fighting, water & wastewater, mining, oil & gas, and others) across six key regions (North America, Latin America, Europe, East Asia, South Asia & Oceania, and Middle East and Africa).

Explore Wide-ranging Coverage of FACT.MR's Industrial Goods Landscape

Crane Pumps Market: Find insights on the Crane Pumps market with analysis of segments, statistics, influencers, market players and strategies adopted over a 10-year forecast period.

Residential Pumps Market: FACT.MR's report on the Residential Pumps market offers insights on the market set for strong growth during 2018-2026, including restraining forces, revenue sources, market leaders, and market strategies.

Self-priming Pumps Market: Read an analysis on the Self-priming Pumps market with insights on growth factors, opportunities, restraints, regional market forecast, regulatory policies, and strengths of market leaders.

About Fact.MR

Fact.MR is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. Fact.MR is headquartered in Dublin, Ireland, and has delivery centers in the U.S. and India. FACT.MR's latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.

Contact:

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
PR- https://www.factmr.com/media-release/1586/global-submersible-pump-market

SOURCE: Fact.MR

ReleaseID: 603445

LA JOLLA, CA / ACCESSWIRE / August 26, 2020 / Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid system, today announced that it will be presenting at the LD 500 Virtual Investor conference being held on September 1-4, 2020.

View Artelo's LD Micro profile here: https://www.ldmicro.com/profile/artl.

Gregory D. Gorgas, President and Chief Executive Officer of Artelo Biosciences, is scheduled to present on Tuesday, September 1st at 10:20 a.m., Eastern Time. The presentation will be webcast live on the conference event platform, which can be accessed here. One-on-one meetings will be held throughout the conference via video conference calls.

The LD 500 Virtual Investor conference will feature the most prominent companies in the small and micro-cap world, alongside interviews and keynotes with thought leaders from various industries.

For conference attendees who wish to schedule a one-on-one meeting with Artelo, please submit your request online via the link provided upon registration or email your request to wade@ldmicro.com. To register for the conference, contact David Scher at david@ldmicro.com or visit https://ld-micro-conference.events.issuerdirect.com/.

Profiles powered by LD Micro – News Compliments of Accesswire

About LD Micro

Back in 2006, LD Micro began with the sole purpose of being an independent resource to the microcap world. What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space. The upcoming LD 500 Virtual Investor conference in September is the Company's most ambitious project yet, and the first event that is accessible to everyone.

About Artelo Biosciences

Artelo Biosciences, Inc. is a San Diego-based biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting the endocannabinoid system and related pathways. Artelo is rapidly advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, pain, and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the company applies leading edge scientific, regulatory, and commercial discipline to develop high-impact therapies. More information is available at www.artelobio.com and Twitter: @ArteloBio.

Investor Relations Contact:

Crescendo Communications, LLC
Tel: 212-671-1020
Email: ARTL@crescendo-ir.com

SOURCE: Artelo Biosciences via LD Micro

ReleaseID: 603451

Orthopedic prosthetic manufacturers are largely displaying interest in artificial intelligence technologies for applications in their product offerings, to increase accuracy of mimicking real limb functions.

DUBAI, UAE / ACCESSWIRE / August 26, 2020 / The worldwide orthopedic prosthetics market is expected to cross a US$ 3.2 billion valuation by the conclusion of the forecasting period in 2030. The covid-19 pandemic has had a moderate effect on the orthopedic prosthetics market. Extensive redirection of healthcare resources by governments and healthcare facilities towards handling the coronavirus crisis has resulted in substantial disruptions and delays in supply chains and delivery schedules, hampering short term growth prospects.

"Rising investments into development of production and designing technologies, aimed towards superior fixation and greater resistance to deterioration, are key factors influencing manufacturers that are likely to bolster demand for years to come," says the FMI analyst

Download a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-1443

Orthopedic Prosthetics Market – Primary Takeaways

Despite higher costs, electric orthopedic prosthetics are displaying growing demand owing to higher accuracy in limb function.
Upper limb applications are accounting for major revenue share, largely owing to growing incidences of sports injuries and AI tech in prosthetics.
Asia Pacific is providing lucrative growth opportunities owing to favorable government initiatives diabetes-related amputations.

Orthopedic Prosthetics Market – Growth Factors

High rate of osteosarcoma is a major generator of demand for orthopedic prosthetic products.
Growing numbers of trauma injuries, coupled with the AI integration into new prosthetic offerings contribute to market growth.

Orthopedic Prosthetics Market – Major Constraints

High costs of purchasing, maintaining, and replacing orthopedic prosthetic devices hold back market growth.
Lack of adequate reimbursement policies is a key challenge restricting adoption rates.

For information on the Research Approach used in the Report, Request Methodology@ https://www.futuremarketinsights.com/askus/rep-gb-1443

The Projected Impact of Coronavirus

The unprecedented burden of the coronavirus crisis on the global healthcare system is creating substantial challenges for players in the orthopedic prosthetics market. Redirection of resources by hospital administration, and governments are limiting the scope of the supply and distribution networks for orthopedic prosthetics. In addition, restrictions on elective medical procedures are hindering market growth in the short term. Demand is likely to recover strongly in the post pandemic period, with new automation technologies gaining traction in the sector.

Competition Landscape

The orthopedic prosthetics market comprises players including but not limited to Fillauer LLC, Zimmer Biomet Holdings Inc., Ossur, B. Braun Melsungen AG, Blatchford Ltd., Hanger Inc., Johnson & Johnson, Smith & Nephew plc., and Otto Bock Healthcare GmbH.

Players in the orthopedic prosthetics market are pushing for business expansion strategies through the use of product launches with improvements to functionality with new tech integration to bolster scope of use.

Request Special Price for this Report to our Sales Executive@ https://www.futuremarketinsights.com/request-special-price/rep-gb-1443

For instance, Mobius Bionics LLC has released (life under kinetic evolution) prosthetic arms offered for veterans in the United States. LegWorks Inc. has unveiled ATK HydraPro, functional prosthetic knee, for waterproof, multi-terrain applications. Also, Next Step Bionics & Prosthetics has unveiled a new osseo-integrated LUKE arm, coupled with post-targeted muscle reinnervation surgery compatibility.

More About the Study

The FMI study provides detailed insights on orthopedic prosthetics market. The market is broken down in terms of product (upper extremity prosthetics, lower extremity prosthetics, liners, sockets, and modular components), technology (conventional, electric powered, and hybrid) and end user (hospitals, prosthetic clinics, rehabilitation centers, and others) across seven key regions (North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa).

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/askus/rep-gb-1443

Explore Future Market Insights Coverage of the Healthcare, Pharmaceuticals, & Medical Devices Industry

Injectable Drug Delivery Market: Find insights on the injectable drug delivery market with segment analysis, statistics, influencing factors, players and key strategies adopted by market players for a 10-year forecast period.

Clinical Trials Market: FMI's report on the clinical trials market offers details on the market between 2019 -2029. The study covers influencers, revenue sources, market leaders, and strategies.

Electronics Medical Records (EMR) Market: Get an in-depth analysis on the electronics medical records (EMR) market with insights on growth levers, opportunities, policies, restraints, regional markets and market leaders.

About Future Market Insights

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/orthopaedic-prosthetics-marke
Press Release Source: https://www.futuremarketinsights.com/press-release/orthopaedic-prosthetics-marke

SOURCE: Future Market Insights

ReleaseID: 603432

VANCOUVER, BC / ACCESSWIRE / August 26, 2020 / Codebase Ventures Inc. ("Codebase" or the "Company") (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) announces that World High Life Plc, (AQSE: LIFE) (OTCQB: WRHLF), in which the Company has invested, has announced that brand ambassador Georges St-Pierre will be showcased on BT Sport, one of Europe's largest sport networks and rights holder for UFC (Ultimate Fighting Championships) in the U.K.

Georges "Rush" St-Pierre, also known as "GSP," is a Canadian professional mixed martial artist and 3-time UFC world champion who holds black belts in both Kyokushin karate and Brazilian Jiu Jitsu. As Brand Ambassador, Mr. St-Pierre facilitates and provides promotional services, including branding, social media, product placement, endorsement and overall support of the World High Life and the Love Hemp brand.

This showcase special on BT Sport will serve to provide a retrospective on Georges' incredible history in the UFC and provide significant exposure for the Love Hemp brand, a World High Life wholly owned subsidiary.

Georges St-Pierre BT Sport Programme Highlights

Georges St-Pierre BT Sport Special will consist of a 5-hour programme, to air on Thursday, August 27th from 9pm to 1am in the UK

The special will consist of a 1-hour interview with Georges wearing Love Hemp branded apparel

The special will include 4 hours of insights from Georges as his favourite fights are showcased

Georges retired from the sport on 13 December 2013, holding the UFC record for most wins in title bouts and then returned to the octagon after a four-year layoff, on 4 November 2017 at UFC 217 in New York City (Madison Square Garden), where he defeated Michael Bisping by submission in the third round to win the UFC Middleweight Championship title, becoming the fourth fighter in the history of the organization to be a multi-division champion. On 7 December 2017, after being diagnosed with ulcerative colitis, Georges vacated his UFC middleweight title and officially announced his retirement from professional MMA competition on 21 February 2019.

In the World High Life announcement, Mr. St-Pierre noted: "I believe that using Love Hemp's CBD products in my training helped my recovery and overall wellbeing greatly, and I embrace this opportunity to help create innovative products and grow the Love Hemp brand so that others can benefit as well. I am committed to building great teams and getting world class results in everything I do, and I am thrilled to contribute to the World High Life and Love Hemp team to help achieve those standards."

About Codebase Ventures Inc.

Codebase Ventures Inc. is an investment company, led by technology and business experts who invest early in great ideas in sectors that have significant upside, including the cannabis sector. We operate from the understanding that technology is always evolving, bringing early opportunities for strategic investments that can deliver the exponential returns to our shareholders. We seek out and empower the innovators who are building tomorrow's standards with platforms, protocols and innovations – not just products. We invest early, support those founders, take their ideas to market, and work tirelessly to help them realize their vision.

For further information, please contact:

George Tsafalas – Ivy Lu
Investor Relations
Telephone: Toll-Free (877) 806-CODE (2633) or 1 (778) 806-5150
E-mail: IR@codebase.ventures

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, joint-ventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking information reflects management's current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "predicts", "intends", "targets", "aims", "anticipates" or "believes" or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward-looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic conditions, industry conditions and dependence upon regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by securities laws.

SOURCE: Codebase Ventures Inc.

ReleaseID: 603361

Players in the medical waste containers market are innovating with the integration of medical waste management and disposal solutions through the integration of IoT and AI technologies.

ROCKVILLE, MD / ACCESSWIRE / August 26, 2020 / The global medical waste containers market is set to display a healthy 5.1% CAGR for the duration of the period of projection between 2020 and 2026. The medical waste containers market is expected to make major gains during the coronavirus pandemic. The unprecedented burden of patients on the global healthcare system, and the resultant increase in medical waste generation during the outbreak has contributed to demand for medical waste containers. Strict regulations implemented for contagion control will also positively contribute to the industry.

"The medical waste container market is intensely competitive owing to the large number of small and large-scale enterprises involved in the industry. Strict guidelines by governments have resulted in developing countries adopting disposable product options, which will support demand in the years ahead," says the FACT.MR report.

Request a sample of the report to gain more market insights at

https://www.factmr.com/connectus/sample?flag=S&rep_id=4819

Medical Waste Containers Market- Key Takeaways

Sharps waste containers account for significant market growth, owing to growing disposal of syringes and infectious waste devices.
Reusable containers are prominent, with environmentally-compliant initiatives being taken up by healthcare facilities.
Asia Pacific is displaying potential for major growth on the back of implementation of strict measures, coupled with higher social awareness.

Medical Waste Containers Market- Driving Factors

High prevalence of chronic ailments and road traffic accidents, and the resultant volumes of medical waste is a major market driver.
Favorable government policies towards medical waste management and disposal programs contribute to market prospects.

Medical Waste Containers Market- Major Restraints

The growing fragmentation of the of the market with the influx of small-scale regional players is a challenge for market growth.
Lack of standardization in terms of regulations in medical waste management and disposal hurts growth prospects.

COVID-19 Impact on Medical Waste Containers Market

The strong demand for hazard free disposal of healthcare waste is causing the sales of medical waste containers to soar during the pandemic. Strict regulations associated to disposal and handling of medical waste is bringing in investments into the industry. Manufacturers are pushing for precautionary measures to reduce disruption to supplies. Puncture resistant biohazard bags are in high demand owing to low costs and efficacy in function. Demand is expected to stay strong even after the end of the crisis period.

Explore the global medical waste containers market with 92 figures, 36 data tables, along with the table of contents of the report. You can also find detailed segmentation on https://www.factmr.com/report/4819/medical-waste-containers-market

Competitive Landscape

Stericycle, Covidien plc, Mauser, Daniels Health, Bemis Manufacturing Company, Sharps Compliance, Becton Dickinson & Co., and Thermo Fisher Scientific, are some of the leading players in the medical waste containers market.

Medical waste containers market players are pushing for product innovation and launch strategies with a growing focus on sustainability and the covid-19 crisis.

For example, Polyfuze Graphics Corp has introduced a new line of anti-microbial, polymer fusion products, including biohazard waste containers and sharps containers. Mediterranean Shipping Company has come up with a Smart Container offsite medical waste product for up to 20 tons of waste processing per day. Mauser Packaging has launched a medical waste container range made from 100% percent recycled plastics from post-consumer packaging waste.

About the Report

This study offers readers a comprehensive market forecast of the medical waste containers market. Global, regional and country-level analysis of the top industry trends impacting the medical waste containers market is covered in this FACT.MR study. The report offers insights on the medical waste containers market on the basis of product (chemotherapy container, biohazard medical waste container, RCRA container, pharmaceutical containers, and sharps containers), waste type (infectious & pathological waste, non-infectious waste, radioactive waste, sharps waste, and pharmaceutical waste) usage type (disposable and reusable) and medical waste generator (hospitals, clinics & physician office, pharma companies, long-term and urgent care centers, pharmacies, and others) across five regions (North America, Latin America, Europe, Asia Pacific, and MEA).

Explore FACT.MR's Comprehensive Coverage of Healthcare Landscape

Medical Waste Management Market– Get the latest insights on the Medical Waste Management market through FACT.MR's report covering analysis for projection period (2020-2026).

Animal Model Market– FACT.MR's study on the global animal model market covers trends, tech innovations, players, and strategies for 2017-2026.

High-Sensitivity Luminometers Market– Obtain analysis on the high-sensitivity luminometers market through FACT.MR's latest report covering competitive analysis, key regions, along with segmental analysis for 2018-2026.

About Fact.MR

Expert analysis, actionable insights, and strategic recommendations of the veteran research team at FACT.MR helps clients from across the globe with their unique business intelligence requirements. With a repository of over a thousand reports and 1 million+ data points, the team has scrutinized the healthcare sector across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services.

Contact:

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
PR- https://www.factmr.com/media-release/1587/global-medical-waste-containers-market

SOURCE: Fact.MR

ReleaseID: 603444

Development of new 3D technology may enable future space missions to print spare battery packs on demand and en route therefore reducing the cost of transport and reserving cargo capacity

SAN DIEGO, CA / ACCESSWIRE / August 26, 2020 / KULR Technology Group, Inc. (OTCQB:KULR) (the "Company" or "KULR") today announces that NASA's Marshall Space Flight Center (MSFC) has awarded the Company a dual-use technology development agreement to build 3D printed battery systems for manned and robotic space applications. KULR's passive propagation resistant (PPR) and internal short circuit (ISC) technologies will be used to develop 3D printed battery systems that meet the JSC 20793 Revision D safety standard created by NASA for crewed space missions.

"NASA employs highly rigorous assurance and safety standards, especially for our man-rated technologies. KULR's PPR design solution for future manned and unmanned space missions is an ideal fit for mass design, flexibility and cost, all the while maintaining this safety rigor through battery risks such as thermal runaway," said NASA MSFC Deputy Chief Technologist John Carr.

Only a handful of groups are working to adapt 3D printing for space application, and NASA's MSFC is at the forefront of engineering excellence for 3D printing technology. MSFC's 3D printing expertise, combined with KULR's proficiency in designing PPR battery packs, establishes the pinnacle in safe battery power systems manufactured in outer space. KULR's PPR solution demonstrated its efficiency when it was used by NASA to transport and store batteries aboard the International Space Station last year.

"Through our partnership with KULR, we will now have the incredible ability to build space-optimized battery pack systems in-orbit," said Brandon Lewis, Human Landing System Cross Program Analysis Coordinator. "We take the safety of our astronauts very seriously. KULR's technologies will enable us to build safer battery packs that prevent dangerous thermal runaway propagation and protect our most valuable assets."

The ability to 3D print in space has numerous advantages, including the potential to make human space exploration less costly; allowing for extended missions; and reserving cargo capacity for other valuable items and/or equipment.

"The optionality to repair and replace battery packs in space with parts 3D printed in space is a complete game changer," said Dr. Timothy Knowles, co-founder and chief technology officer of KULR. "3D printing of KULR's PPR battery design will help lower the costs associated with battery pack transportation for the upcoming Artemis missions, where NASA will build sustainable elements on and around the moon in preparation for an eventual human mission to Mars."

About KULR Technology Group, Inc.

KULR Technology Group, Inc. develops, manufactures and licenses next-generation carbon fiber thermal management technologies for batteries and electronic systems. Leveraging the company's roots in developing breakthrough cooling solutions for NASA space missions and backed by a strong intellectual property portfolio, KULR enables leading aerospace, electronics, energy storage, 5G infrastructure, and electric vehicle manufacturers to make their products cooler, lighter and safer for the consumer. For more information, please visit www.kulrtechnology.com.

Safe Harbor Statement

This release does not constitute an offer to sell or a solicitation of offers to buy any securities of any entity. This release contains certain forward-looking statements based on our current expectations, forecasts and assumptions that involve risks and uncertainties. Forward-looking statements in this release are based on information available to us as of the date hereof. Our actual results may differ materially from those stated or implied in such forward-looking statements, due to risks and uncertainties associated with our business, which include the risk factors disclosed in our Form 10-K filed on May 14, 2020. Forward-looking statements include statements regarding our expectations, beliefs, intentions or strategies regarding the future and can be identified by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," and "would" or similar words. All forecasts are provided by management in this release are based on information available at this time and management expects that internal projections and expectations may change over time. In addition, the forecasts are entirely on management's best estimate of our future financial performance given our current contracts, current backlog of opportunities and conversations with new and existing customers about our products and services. We assume no obligation to update the information included in this press release, whether as a result of new information, future events or otherwise.

Investor Relations:

Keith Pinder
Landon Capital
Main: (404) 995-6671
kpinder@landoncapital.net

Media Contact:
Derek Newton
Head, Media Relations
Main: (786) 499-8998
derek.newton@kulrtechnology.com

SOURCE: KULR Technology Group, Inc.

ReleaseID: 603454

CALGARY, AB / ACCESSWIRE / August 26, 2020 / Plexus Technology ("Plexus") is pleased to announce the closing of $5,500,000 CAD in financing, effective July 31st, 2020, for the advancement of their natural gas supplied power generation projects near Langdon, Alberta, Canada. Plexus believes that the combined electricity demand from Big Data, Blockchain, Artificial Intelligence and Edge Computing will grow exponentially in the future. Having access to low-cost, long-life energy will position Plexus as a leader in these exciting new industries.

Proof Capital Inc. ("Proof"), based in Calgary, Alberta, acted as both financial advisor and lead investor in the transaction. Steve Vannatta, Founder/Partner, Plexus Technology said "We are very excited to be working with Proof Capital as our financial partner. Proof brings to Plexus a wealth of knowledge and insight in capital markets and financial structuring.".

About Plexus Technology

Plexus Technology is an Alberta based company partnering with Oil and Gas producers to off-take their natural gas (pre-sales line) to generate electricity for industrial load data centers. By partnering with Alberta energy producers, Plexus utilizes natural gas to create extremely low-cost electricity – $0.025KWh USD vs the global average of $0.08KWh USD. Plexus has a right of first refusal (ROFR) to expand up to 200MW of power generation. Phase 1 is nearing completion and consists of 5MW of power generation. Phase 2 and Phase 3 combined will add another 10MW of power generation to the Alberta portfolio. Phase 2 is expected to be online before the end of this year, with Phase 3 coming online by Q2 2021. For more information about Plexus, please visit www.plexuscorp.ca

About Proof Capital Inc.

Proof Capital Inc. is a merchant bank and wealth management firm that specializes in private investments in alternative assets. Jeremy Kaliel, CEO of Proof Capital, will be joining Plexus' board of directors. For more information about Proof, please visit www.proofcapital.ca.

"We are proud to have achieved this institutional financing milestone for our company and feel this plan puts Plexus in a very strong position to navigate the current market volatility, while delivering exceptional returns for our shareholders," Mike Kennedy, CEO, Plexus Technology.

We appreciate your continued support and are available to discuss any questions or concerns.

Steve Vannatta, CFA
Founder/Partner, Plexus Technology Corporation
647-638-3435 | steve.vannatta@plexuscorp.ca
www.plexuscorp.ca

SOURCE: Plexus Technology Corp.

ReleaseID: 603008